Compare Sana Biotechnology Inc (SANA) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs TotalEnergies SE — how do they compare? Sana Biotechnology Inc trades at $2.79 (market cap $836.71M), while TotalEnergies SE trades at $86.11 (market cap $191.82B). The key difference: TotalEnergies SE is far larger — about 229.3× Sana Biotechnology Inc's market cap, and TotalEnergies SE pays a 4.93% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 23 Days and TotalEnergies SE for 90 Days on average.
| SANA | TTE | |
|---|---|---|
Market Cap | $836.71M | $191.82B |
Volume | 4,507,444 | 3,311,339 |
Sector | Health | Energy |
52-Week High | $5.92 | $93.60 |
52-Week Low | $2.68 | $57.39 |
Typical Hold Time | 23 Days | 90 Days |
Enterprise Value | $749.96M | $222.81B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.79, up 2.57% today, but faces significant fundamental challenges with no revenue, negative earnings, and substantial cash burn. The technical picture remains bearish with moving averages signaling continued downward pressure, though oscillators show neutral conditions. Recent earnings have been mixed with two misses and one beat against expectations, while analyst sentiment remains overwhelmingly positive with 82% buy ratings.
The outlook hinges on SANA's clinical pipeline success and future revenue generation capabilities. Investment opportunity exists in the company's promising biotechnology platform and strong analyst support, but risks include continued cash burn, lack of current revenue, and execution challenges in bringing therapies to market. The stock represents a high-risk, high-reward biotechnology investment.
TotalEnergies (TTE) trades at $86.02, up 2.13% for the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue declined to $182.34B in 2025, though net income margin held at 9.08%. Recent news highlights a $10B investment in Argentina and a strategic focus on boosting cash flow and dividends through 2030.
TTE offers value with a P/E of 10.77 and strong cash generation, supported by a 55.88% analyst buy rating and a $95.33 consensus price target. Risks include declining revenue trends, geopolitical exposure, and energy price volatility. The stock presents a balanced opportunity for income and growth investors, with upside potential if execution on expansion plans materializes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
